Live Breaking News & Updates on Jared holz

Stay informed with the latest breaking news from Jared holz on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jared holz and stay connected to the pulse of your community

J&J to buy Santa Clara-based Shockwave for $13 billion in medical device play

J&J has been rapidly building its portfolio in both medical technology and drug development to help prepare for the impending loss of exclusivity for Stelara, its top-selling drug for psoriasis, in the US next year.

Boston , Massachusetts , United-states , New-york , Mizuho-jared-holz , Gerry-smith , John-lauerman-bloomberg , Abiomed , Shockwave-medical-inc , Jpmorgan-securities , Ambrx-biopharma-inc , Boston-scientific-corp

J&J to buy Santa Clara-based Shockwave for $13 billion in medical device play

J&J has been rapidly building its portfolio in both medical technology and drug development to help prepare for the impending loss of exclusivity for Stelara, its top-selling drug for psoriasis, in the US next year.

Boston , Massachusetts , United-states , New-york , John-lauerman-bloomberg , Mizuho-jared-holz , Gerry-smith , Johnson , Ambrx-biopharma-inc , Jpmorgan-securities , Shockwave-medical-inc , Abiomed

Biotech Stocks Are on a Tear. They Could Keep Climbing

An ETF that tracks the biotech sector closed above $100 for the first time in just over two years on Tuesday.

Eli-lilly , Juliette-lafille , Jared-holz , Tim-opler , Josh-nathan-kazis , Novo-nordisk , Deutsche-bank , Viking-therapeutics , Denali-therapeutics ,

Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion

"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to get," Mizuho strategist Jared Holz said.

New-york , United-states , Dallas , Texas , Miami , Florida , America , Jared-holz , Eli-lilly , Berkshire-hathaway , Novo-nordisk , Wall-street

Eli Lilly Rides the Weight-Loss-Drug Wave to Record, Hits $700 Billion

"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to get," Mizuho strategist Jared Holz said.

Dallas , Texas , United-states , New-york , Miami , Florida , America , Eli-lilly , Jared-holz , Terms-of-service , Novo-nordisk , Berkshire-hathaway

Eli Lilly CFO: Weight-loss drug demand will outstrip GLP-1 supply through 2024

Eli Lilly blew past Wall Street estimates for its latest earnings but faces pressure ahead to deliver strong results for the year.

Jared-holz , Eli-lilly , Wall-street , Avid-ricks , Eight-loss , Arket-demand ,

J&J slides as device margins droop, drug sales seen falling

J&J slides as device margins droop, drug sales seen falling
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , New-york , Boston , Massachusetts , Mizuho-jared-holz , Vijay-kumar , Joe-wolk , Johnson , Abbott-laboratories , Boston-scientific-corp , Kenvue-inc

J&J Slides as Device Margins Droop, Drug Sales Seen Falling

(Bloomberg) -- Johnson & Johnson shares tumbled after the company said profit margins in its medical device and technology unit fell last quarter and drug sales will be lower in the second half of the year than the first.Most Read from BloombergChina Weighs Stock Market Rescue Package Backed by $278 BillionNetflix Pays $5 Billion for ‘Raw’ in Bet on Live EventsAn Isolated Israel Doubles Down on War in Gaza — At All CostsIndia Tops Hong Kong as World’s Fourth-Largest Stock MarketHong Kong Stocks

Texas , United-states , Boston , Massachusetts , New-york , Gerry-smith , Mizuho-jared-holz , Bloomberg-johnson , Joe-wolk , Vijay-kumar , Bloomberg-businessweek , Boston-scientific

Healthcare: Citi and others are bullish on biotech, medtech and more

2023 wasn't a good year for the health-care sector, but some investors expect it to rebound this year — highlighting biotech and medical tech as areas to watch.

Jared-holz , Matt-orton , Abbott-laboratories , Alnylam-pharmaceuticals , Global-wealth-investments , Biomea-fusion , Mizuho-securities-americas , Trent-masters , Intuitive-surgical , Raymond-james-investment-management , Stock-markets , Biotech-and-pharmaceuticals

Experts react to UnitedHealth seeing elevated medical costs in Q4

Experts react to UnitedHealth seeing elevated medical costs in Q4
invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.

Jared-holz , Blake-madden , Courtney-garcia , Unitedhealth-group-inc , Featured-broker , Scott-nations , Nations-indexes , Unitedhealth-group , Payne-capital-management ,